BIN1 tumor suppressor regulates Fas/Fas ligand–mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma

AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders

(2015) Sharmin Esmailzadeh et al.   Oncotarget

Novel therapies for cutaneous T-cell lymphoma: what does the future hold?

(2014) Emmanuella Guenova et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Lessons learned from gene expression profiling of cutaneous T-cell lymphoma

(2013) B.O. Dulmage et al.   BRITISH JOURNAL OF DERMATOLOGY

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex

(2013) Min Chen et al.   JNCI-Journal of the National Cancer Institute

Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL/CD95L transcription

(2011) Y. Wang et al.   BLOOD

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

(2011) U. Ralfkiaer et al.   BLOOD

Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy

(2011) Ahmad R. Safa et al.   Cancers

In vitro and in vivo characterisation of a novel c-FLIP-targeted antisense phosphorothioate oligonucleotide

(2010) Andrew E. Logan et al.   APOPTOSIS

Structural alterations of the FAS gene in cutaneous T-cell lymphoma (CTCL)

(2010) Jianqiang Wu et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Identification of c-FLIPL and c-FLIPS as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells

(2010) C. Haag et al.   GUT

The role of c-FLIPL in ovarian cancer: Chaperoning tumor cells from immunosurveillance and increasing their invasive potential

(2010) Ahmed El-Gazzar et al.   GYNECOLOGIC ONCOLOGY

Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators ofAHI-1oncogene in primary and transformed CTCL cells

(2009) Erin Kennah et al.   BLOOD

The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage

(2009) E K Cassimere et al.   CELL DEATH AND DIFFERENTIATION

c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells

(2008) Travis W. Day et al.   BIOCHEMICAL PHARMACOLOGY

Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression

(2008) E. Contassot et al.   BLOOD

Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome

(2008) R. van Doorn et al.   BLOOD

Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy

(2008) Ahmad Safa et al.   CURRENT CANCER DRUG TARGETS

Adenovirus E1A oncoprotein liberates c‐Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1‐dependent mechanism

(2008) Erica L. Kinney et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS

(2008) Xin Mao et al.   JOURNAL OF CUTANEOUS PATHOLOGY

AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells

(2008) Liang L. Zhou et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation

(2008) Jianqiang Wu et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Mycosis fungoides and Sézary syndrome

(2008) Sam T Hwang et al.   LANCET